ACELYRIN, Total Stockholder Equity vs Other Liab Analysis

SLRN Stock

USD 4.55 0.02 0.44%

ACELYRIN, INC financial indicator trend analysis is way more than just evaluating ACELYRIN, INC Common prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ACELYRIN, INC Common is a good investment. Please check the relationship between ACELYRIN, INC Total Stockholder Equity and its Other Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Total Stockholder Equity vs Other Liab

Total Stockholder Equity vs Other Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ACELYRIN, INC Common Total Stockholder Equity account and Other Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between ACELYRIN, INC's Total Stockholder Equity and Other Liab is -0.95. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Other Liab in the same time period over historical financial statements of ACELYRIN, INC Common, assuming nothing else is changed. The correlation between historical values of ACELYRIN, INC's Total Stockholder Equity and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of ACELYRIN, INC Common are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Total Stockholder Equity i.e., ACELYRIN, INC's Total Stockholder Equity and Other Liab go up and down completely randomly.

Correlation Coefficient

-0.95

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Other Liab

Most indicators from ACELYRIN, INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ACELYRIN, INC Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

As of the 29th of November 2024, Selling General Administrative is likely to drop to about 34.4 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 353 M

ACELYRIN, INC fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Other Liab	Net Receivables	Inventory	Deferred Long Term Liab	Non Current Liabilities Other
Total Assets		0.94	1.0	0.86	-0.86	-0.8	-0.96	0.91	0.81	1.0	0.9	0.91	1.0	0.94	-0.28	0.9	0.83	-0.01	0.86	1.0	1.0	-0.73	0.95	0.95	-0.73	-0.73
Other Current Liab	0.94		0.96	0.89	-0.64	-0.55	-0.86	0.89	0.55	0.91	0.69	0.73	0.94	1.0	-0.56	0.89	0.89	-0.34	0.89	0.94	0.93	-0.71	0.99	0.99	-0.71	-0.71
Total Current Liabilities	1.0	0.96		0.87	-0.83	-0.76	-0.95	0.91	0.77	0.99	0.87	0.89	1.0	0.96	-0.33	0.91	0.85	-0.07	0.87	1.0	1.0	-0.73	0.96	0.96	-0.73	-0.73
Total Stockholder Equity	0.86	0.89	0.87		-0.69	-0.58	-0.91	0.99	0.57	0.83	0.67	0.79	0.86	0.9	-0.66	0.99	1.0	-0.42	1.0	0.86	0.86	-0.95	0.95	0.94	-0.95	-0.95
Net Tangible Assets	-0.86	-0.64	-0.83	-0.69		0.99	0.92	-0.79	-0.99	-0.89	-0.99	-0.99	-0.86	-0.65	-0.1	-0.78	-0.63	-0.37	-0.69	-0.86	-0.86	0.7	-0.69	-0.69	0.7	0.7
Net Debt	-0.8	-0.55	-0.76	-0.58	0.99		0.86	-0.7	-1.0	-0.84	-0.98	-0.96	-0.81	-0.57	-0.23	-0.69	-0.52	-0.49	-0.58	-0.8	-0.81	0.61	-0.6	-0.6	0.61	0.61
Retained Earnings	-0.96	-0.86	-0.95	-0.91	0.92	0.86		-0.96	-0.85	-0.96	-0.91	-0.97	-0.96	-0.87	0.29	-0.96	-0.88	0.02	-0.91	-0.96	-0.96	0.87	-0.91	-0.9	0.87	0.87
Accounts Payable	0.91	0.89	0.91	0.99	-0.79	-0.7	-0.96		0.69	0.89	0.77	0.88	0.91	0.9	-0.53	1.0	0.97	-0.28	0.99	0.91	0.91	-0.95	0.95	0.94	-0.95	-0.95
Cash	0.81	0.55	0.77	0.57	-0.99	-1.0	-0.85	0.69		0.85	0.98	0.95	0.81	0.57	0.25	0.68	0.51	0.51	0.57	0.81	0.81	-0.59	0.6	0.59	-0.59	-0.59
Non Current Assets Total	1.0	0.91	0.99	0.83	-0.89	-0.84	-0.96	0.89	0.85		0.93	0.93	1.0	0.92	-0.21	0.89	0.8	0.06	0.83	1.0	1.0	-0.72	0.92	0.92	-0.72	-0.72
Non Currrent Assets Other	0.9	0.69	0.87	0.67	-0.99	-0.98	-0.91	0.77	0.98	0.93		0.97	0.9	0.71	0.11	0.76	0.62	0.38	0.67	0.9	0.91	-0.64	0.73	0.73	-0.64	-0.64
Other Assets	0.91	0.73	0.89	0.79	-0.99	-0.96	-0.97	0.88	0.95	0.93	0.97		0.91	0.75	-0.06	0.87	0.75	0.22	0.79	0.91	0.92	-0.79	0.79	0.79	-0.79	-0.79
Cash And Short Term Investments	1.0	0.94	1.0	0.86	-0.86	-0.81	-0.96	0.91	0.81	1.0	0.9	0.91		0.94	-0.28	0.9	0.83	-0.01	0.86	1.0	1.0	-0.73	0.95	0.95	-0.73	-0.73
Common Stock Shares Outstanding	0.94	1.0	0.96	0.9	-0.65	-0.57	-0.87	0.9	0.57	0.92	0.71	0.75	0.94		-0.55	0.9	0.89	-0.32	0.9	0.94	0.94	-0.72	0.99	0.99	-0.72	-0.72
Non Current Liabilities Total	-0.28	-0.56	-0.33	-0.66	-0.1	-0.23	0.29	-0.53	0.25	-0.21	0.11	-0.06	-0.28	-0.55		-0.54	-0.71	0.96	-0.66	-0.28	-0.27	0.57	-0.57	-0.57	0.57	0.57
Other Current Assets	0.9	0.89	0.91	0.99	-0.78	-0.69	-0.96	1.0	0.68	0.89	0.76	0.87	0.9	0.9	-0.54		0.98	-0.29	0.99	0.9	0.9	-0.95	0.95	0.94	-0.95	-0.95
Other Stockholder Equity	0.83	0.89	0.85	1.0	-0.63	-0.52	-0.88	0.97	0.51	0.8	0.62	0.75	0.83	0.89	-0.71	0.98		-0.48	1.0	0.83	0.83	-0.94	0.94	0.94	-0.94	-0.94
Total Liab	-0.01	-0.34	-0.07	-0.42	-0.37	-0.49	0.02	-0.28	0.51	0.06	0.38	0.22	-0.01	-0.32	0.96	-0.29	-0.48		-0.42	-0.01	-0.01	0.34	-0.34	-0.34	0.34	0.34
Net Invested Capital	0.86	0.89	0.87	1.0	-0.69	-0.58	-0.91	0.99	0.57	0.83	0.67	0.79	0.86	0.9	-0.66	0.99	1.0	-0.42		0.86	0.86	-0.95	0.95	0.94	-0.95	-0.95
Total Current Assets	1.0	0.94	1.0	0.86	-0.86	-0.8	-0.96	0.91	0.81	1.0	0.9	0.91	1.0	0.94	-0.28	0.9	0.83	-0.01	0.86		1.0	-0.73	0.95	0.95	-0.73	-0.73
Net Working Capital	1.0	0.93	1.0	0.86	-0.86	-0.81	-0.96	0.91	0.81	1.0	0.91	0.92	1.0	0.94	-0.27	0.9	0.83	-0.01	0.86	1.0		-0.73	0.94	0.94	-0.73	-0.73
Other Liab	-0.73	-0.71	-0.73	-0.95	0.7	0.61	0.87	-0.95	-0.59	-0.72	-0.64	-0.79	-0.73	-0.72	0.57	-0.95	-0.94	0.34	-0.95	-0.73	-0.73		-0.8	-0.8	1.0	1.0
Net Receivables	0.95	0.99	0.96	0.95	-0.69	-0.6	-0.91	0.95	0.6	0.92	0.73	0.79	0.95	0.99	-0.57	0.95	0.94	-0.34	0.95	0.95	0.94	-0.8		1.0	-0.8	-0.8
Inventory	0.95	0.99	0.96	0.94	-0.69	-0.6	-0.9	0.94	0.59	0.92	0.73	0.79	0.95	0.99	-0.57	0.94	0.94	-0.34	0.94	0.95	0.94	-0.8	1.0		-0.8	-0.8
Deferred Long Term Liab	-0.73	-0.71	-0.73	-0.95	0.7	0.61	0.87	-0.95	-0.59	-0.72	-0.64	-0.79	-0.73	-0.72	0.57	-0.95	-0.94	0.34	-0.95	-0.73	-0.73	1.0	-0.8	-0.8		1.0
Non Current Liabilities Other	-0.73	-0.71	-0.73	-0.95	0.7	0.61	0.87	-0.95	-0.59	-0.72	-0.64	-0.79	-0.73	-0.72	0.57	-0.95	-0.94	0.34	-0.95	-0.73	-0.73	1.0	-0.8	-0.8	1.0

Click cells to compare fundamentals

ACELYRIN, INC Account Relationship Matchups

Pair Trading with ACELYRIN, INC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACELYRIN, INC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACELYRIN, INC will appreciate offsetting losses from the drop in the long position's value.

Moving together with ACELYRIN, Stock

0.7

EWTX

Edgewise Therapeutics

Pair Corr

Moving against ACELYRIN, Stock

0.6	ELAN	Elanco Animal Health	Pair Corr
0.35	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.32	HLN	Haleon plc	Pair Corr

The ability to find closely correlated positions to ACELYRIN, INC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ACELYRIN, INC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ACELYRIN, INC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ACELYRIN, INC Common to buy it.

The correlation of ACELYRIN, INC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ACELYRIN, INC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ACELYRIN, INC Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for ACELYRIN, INC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether ACELYRIN, INC Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ACELYRIN, INC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acelyrin, Inc Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acelyrin, Inc Common Stock:

How To Invest In ACELYRIN,

Details

Is ACELYRIN, Stock a good investment?

Details

What is ACELYRIN, INC's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.46)

Return On Assets

(0.33)

Return On Equity

(0.42)

The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ACELYRIN, Total Stockholder Equity vs Other Liab Analysis

Total Stockholder Equity vs Other Liab

Total Stockholder Equity vs Other Liab Correlation Analysis

Correlation Coefficient

Total Stockholder Equity

Other Liab

ACELYRIN, INC fundamental ratios Correlations

ACELYRIN, INC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pair Trading with ACELYRIN, INC

Moving together with ACELYRIN, Stock

Moving against ACELYRIN, Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Common Stock Shares Outstanding	+ 1.0	Other Current Liab

Cash	- 1.0	Net Debt
Other Assets	- 0.99	Net Tangible Assets
Non Currrent Assets Other	- 0.99	Net Tangible Assets
Cash	- 0.99	Net Tangible Assets
Non Currrent Assets Other	- 0.98	Net Debt
Other Assets	- 0.97	Retained Earnings